Zobrazeno 1 - 10
of 58
pro vyhledávání: '"K. Blumenstengel"'
Autor:
Thomas Steiner, Marc-Oliver Grimm, Carsten-Henning Ohlmann, Friedrich Overkamp, M. Groschek, G. Pühse, Edwin Herrmann, Norbert Marschner, U. Hutzschenreuter, K. Blumenstengel
Publikováno v:
World Journal of Urology. 29:361-366
To investigate whether patients with metastatic renal cell carcinoma benefit from sequential therapies with the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib. A total of 89 patients were treated in nine German centres between 2002 and 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e52ff9c1e2a962547d91a512c5be1c
https://doi.org/10.1007/s00345-011-0673-4
https://doi.org/10.1007/s00345-011-0673-4
Autor:
Anja Rogler, P. J. Goebell, K. Blumenstengel, Norbert Marschner, Christian Doehn, Ulrich Kube, Marc-Oliver Grimm, Lothar Bergmann, Edwin Herrmann, Anja Dietel, Michael Scheffler
Publikováno v:
Journal of Clinical Oncology. 36:631-631
631 The EVERPRO study: Final results of a non-interventional study evaluating QoL in second-line treatment of mRCC with everolimus Background: Although the prognosis of mRCC patients remains poor, median overall survival has improved since 2006, prob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75be99a638457f0d987a4076816147eb
https://doi.org/10.1200/jco.2018.36.6_suppl.631
https://doi.org/10.1200/jco.2018.36.6_suppl.631
Autor:
C. Hering-Schubert, J. Germeroth, S. Karsten, M. Stauch, N. Nagel, K Blumenstengel, A. Glandt, A. Crispin
Publikováno v:
Aktuelle Ernährungsmedizin. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d4e44afc172e2c54ef8b6f5cc9fe51
https://doi.org/10.1055/s-0034-1375861
https://doi.org/10.1055/s-0034-1375861
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 127:48-54
Bendamustine, an alkylating agent without cross-resistance to cyclophosphamide is active in a variety of lymphoproliferative and other malignancies. In an open phase-II study we treated 23 patients with a median age of 62 years at study entry (43-86
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a861167c4907d3b85a9779fe3fdef0b
https://doi.org/10.1007/s004320000180
https://doi.org/10.1007/s004320000180
Autor:
Wolfgang Knauf, Juergen Barth, Ninia Detlefsen, Jochen Eggert, Martin Goerner, K. Blumenstengel, Frank Kauff, Rudolf Weide, Ulrike Soeling, Mathias J. Rummel, Axel Hinke, Georg Schliesser, Elisabeth Lange, Bernd Hertenstein
Publikováno v:
Journal of Clinical Oncology. 34:7503-7503
7503Background: Rituximab maintenance is part of a standard treatment approach for follicular lymphoma. In mantle cell lymphoma (MCL), however, it is not yet common practice. In this study we compa...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11b3f1a611074bf9aff7b4796a46f237
https://doi.org/10.1200/jco.2016.34.15_suppl.7503
https://doi.org/10.1200/jco.2016.34.15_suppl.7503
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 126(8)
Low grade non-Hodgkin lymphomas (l-NHL) are rarely showing complete or sustained remissions to conventional chemotherapy. Thus, many therapeutic strategies try to improve the remission rates and outcome in relapsed and refractory l-NHL. Bendamustine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::616039baee23038a536d4e24f0f9bf79
https://pubmed.ncbi.nlm.nih.gov/11256023
https://pubmed.ncbi.nlm.nih.gov/11256023
Publikováno v:
Intensivtherapie bei Sepsis und Multiorganversagen ISBN: 9783662079638
Sepsis und MODS ISBN: 3540000046
Sepsis und MODS ISBN: 3540000046
Das Ziel in der Therapie maligner Erkrankungen ist es, in einem moglichst hohen Prozentsatz der Patienten langfristig Krankheitsfreiheit oder eine Heilung zu erreichen. Die dabei in der zuruckliegenden Zeit erzielten Erfolge beruhen in erster Linie a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c5446692ce50b9befc10d21fa6425e
https://doi.org/10.1007/978-3-662-07962-1_17
https://doi.org/10.1007/978-3-662-07962-1_17
Autor:
H, Link, K, Blumenstengel, A, Böhme, O, Cornely, O, Kellner, M R, Nowrousian, H, Ostermann, X, Schiel, M, Wilhelm
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1906040f3fc86915d2a86364a879d528
https://pubmed.ncbi.nlm.nih.gov/10410648
https://pubmed.ncbi.nlm.nih.gov/10410648
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 124(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ca109ac9a6e7fe6532a702862fe781c
https://pubmed.ncbi.nlm.nih.gov/10191828
https://pubmed.ncbi.nlm.nih.gov/10191828
Publikováno v:
Journal of cancer research and clinical oncology. 124(6)
We examined the efficiency of disease-specific "standard" chemotherapies epirubicin, cyclophosphamide (EC); cyclophosphamide, vincristine, doxorubicin, etoposide, prednisolone (CHOEP); epirubicin, ifosfamide (EPI/IFOS) for peripheral blood progenitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb276acea3ef20c42d5ba0aa761b74b
https://pubmed.ncbi.nlm.nih.gov/9692843
https://pubmed.ncbi.nlm.nih.gov/9692843